HUP0500259A2 - Új N-(transz-4-izopropil-ciklohexil-karbonil)-D-fenil-alanin forma, eljárás előállítására és alkalmazása - Google Patents

Új N-(transz-4-izopropil-ciklohexil-karbonil)-D-fenil-alanin forma, eljárás előállítására és alkalmazása

Info

Publication number
HUP0500259A2
HUP0500259A2 HU0500259A HUP0500259A HUP0500259A2 HU P0500259 A2 HUP0500259 A2 HU P0500259A2 HU 0500259 A HU0500259 A HU 0500259A HU P0500259 A HUP0500259 A HU P0500259A HU P0500259 A2 HUP0500259 A2 HU P0500259A2
Authority
HU
Hungary
Prior art keywords
phenylalanine
trans
isopropylcylohexylcarbonyl
production
novel form
Prior art date
Application number
HU0500259A
Other languages
English (en)
Hungarian (hu)
Inventor
Shanmughasamy Rajamahendra
Chandrashekar Aswathanarayanappa
Tom Thomas Puthiaprampil
Madhavan Sridharan
Sambasivam Ganesh
Original Assignee
Biocon Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Limited filed Critical Biocon Limited
Publication of HUP0500259A2 publication Critical patent/HUP0500259A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0500259A 2002-04-29 2002-04-29 Új N-(transz-4-izopropil-ciklohexil-karbonil)-D-fenil-alanin forma, eljárás előállítására és alkalmazása HUP0500259A2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000114 WO2003093222A1 (en) 2002-04-29 2002-04-29 Novel form of n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine

Publications (1)

Publication Number Publication Date
HUP0500259A2 true HUP0500259A2 (hu) 2005-06-28

Family

ID=29287383

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0500259A HUP0500259A2 (hu) 2002-04-29 2002-04-29 Új N-(transz-4-izopropil-ciklohexil-karbonil)-D-fenil-alanin forma, eljárás előállítására és alkalmazása

Country Status (13)

Country Link
US (1) US7314955B2 (enExample)
EP (1) EP1499586A4 (enExample)
JP (1) JP4137053B2 (enExample)
KR (1) KR20040111490A (enExample)
AU (1) AU2002304281A1 (enExample)
CA (1) CA2481322A1 (enExample)
CZ (1) CZ2004997A3 (enExample)
HR (1) HRP20040920A2 (enExample)
HU (1) HUP0500259A2 (enExample)
IL (1) IL164327A0 (enExample)
MX (1) MXNL04000084A (enExample)
SK (1) SK287644B6 (enExample)
WO (1) WO2003093222A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2004997A3 (cs) 2002-04-29 2005-01-12 Biocon Limited Nová forma N-(trans-4-isopropylcyklohexylkarbonyl)-D-fenylalaninu
US6861553B2 (en) 2002-07-03 2005-03-01 Teva Pharmaceuticals Industries Ltd. Process for preparing nateglinide and intermediates thereof
US7148376B2 (en) 2002-07-18 2006-12-12 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7358390B2 (en) 2002-07-18 2008-04-15 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7420084B2 (en) 2002-07-18 2008-09-02 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7534913B2 (en) 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
WO2004020396A1 (en) * 2002-08-28 2004-03-11 Dr. Reddy's Laboratories Limited Crystalline form of nateglinide and process for preparation thereof
WO2004074330A1 (ja) * 2003-02-18 2004-09-02 Konishi Co., Ltd. 硬化性樹脂、その製造方法及び硬化性樹脂組成物
HU227073B1 (hu) * 2003-07-10 2010-06-28 Richter Gedeon Nyrt Eljárás királisan tiszta N-(transz-4-izopropil-ciklohexilkarbonil)-D-fenil-alanin (nateglinid) és kristálymódosulatainak elõállítására, valamint a G-kristálymódosulata
US20070231393A1 (en) * 2004-05-19 2007-10-04 University Of South Carolina System and Device for Magnetic Drug Targeting with Magnetic Drug Carrier Particles
GB0413084D0 (en) * 2004-06-11 2004-07-14 Cipla Ltd Process
US20100004334A1 (en) * 2008-07-01 2010-01-07 Mead Johnson Nutrition Company Nutritional Compositions Containing Punicalagins
US11390830B2 (en) 2018-10-05 2022-07-19 The Chemours Company Fc, Llc Compositions comprising 1,2-dichloro-1,2-difluoroethylene for use in cleaning and solvent applications

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
US4814684A (en) * 1987-09-30 1989-03-21 Trw Inc. Apparatus for extending the Vout/Vin ratio of a DC-to-DC converter
EP0526171B1 (en) * 1991-07-30 1997-03-05 Ajinomoto Co., Inc. Crystals of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine and methods for preparing them
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
CZ2004997A3 (cs) 2002-04-29 2005-01-12 Biocon Limited Nová forma N-(trans-4-isopropylcyklohexylkarbonyl)-D-fenylalaninu

Also Published As

Publication number Publication date
SK50052004A3 (sk) 2005-03-04
WO2003093222A1 (en) 2003-11-13
EP1499586A1 (en) 2005-01-26
KR20040111490A (ko) 2004-12-31
US20050165108A1 (en) 2005-07-28
IL164327A0 (en) 2005-12-18
MXNL04000084A (es) 2006-02-28
EP1499586A4 (en) 2006-01-18
JP2005523933A (ja) 2005-08-11
JP4137053B2 (ja) 2008-08-20
HRP20040920A2 (en) 2005-02-28
SK287644B6 (sk) 2011-05-06
CZ2004997A3 (cs) 2005-01-12
AU2002304281A1 (en) 2003-11-17
CA2481322A1 (en) 2003-11-13
US7314955B2 (en) 2008-01-01

Similar Documents

Publication Publication Date Title
HUP0500259A2 (hu) Új N-(transz-4-izopropil-ciklohexil-karbonil)-D-fenil-alanin forma, eljárás előállítására és alkalmazása
ECSP095220A (es) Derivados de n-fenil-2-pirimidin-amina
AU2002258066A1 (en) Dermatological and cosmetic compositions
PL1657991T3 (pl) Naszyjniki i bransoletki z ustalaczami
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
BR0112812A (pt) Titanato de potássio e magnésio lepidocrocìtico, método para fabricar o mesmo e material de fricção
NO20082768L (no) Levodopa prodroge mesylat, sammensetninger og anvendelser derav
WO2003008583A3 (en) Novel compositions and methods for cancer
AU2003300368A1 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
AU2003270022A1 (en) Method and apparatus for the manufacture of high temperature materials by combustion synthesis and semi-solid forming
ZA200307449B (en) Process and apparatus for the preparation of synthesis gas.
MXPA05010855A (es) Metodo para obtener galio-68 y uso del mismo y dispositivo para realizar dicho metodo.
WO2003007803A3 (en) Methods for diagnosing and treating alzheimer's disease and parkinson's disease
JO2793B1 (en) The new crystalline form 5 of agomelatine, its preparation process and the pharmaceutical ingredients it contains
MXPA05004621A (es) Derivados de anilinopirazol utiles en el tratamiento de la diabetes.
EP2607370A3 (en) Amorphous form of beta- L-2'-deoxythymidine
UA83719C2 (ru) Кристаллическая форма iii агомелатина, способ ее получения и фармацевтическая композиция, которая ее содержит
NO20055741D0 (no) Nye kjemiske forbindelser
JP2005523933A5 (enExample)
TW200504402A (en) Antimicrobial lenses, processes to prepare them and methods of their use
WO2004026258A3 (en) Modulating vesicular monoamine transporter trafficking and function: a novel approach for the treatment of parkinson’s disease
HUP0300231A3 (en) Process for the preparation of high purity perindopril and intermediates useful in the synthesis, pharmaceutical compositions containing the compound and their use
EP1505139A4 (en) THICKENERS, THIS INCLUDING COSMETICS AND ITS MANUFACTURING PROCESS
WO2006116349A3 (en) Sustained release formulation and dosing schedules of leukotriene synthesis inhibitor for human therapy
WO2003053224A3 (en) Novel compositions and methods for cancer

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees